Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs
- 10 March 2006
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 24 (11), 1928-1940
- https://doi.org/10.1016/j.vaccine.2005.10.052
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- Selective enhancement of the type 1 cytokine response by expression of a canine interleukin (IL)-12 fused heterodimeric DNAVeterinary Immunology and Immunopathology, 2006
- Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantumVaccine, 2005
- Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. IranVaccine, 2004
- Reduced immunogenicity of DNA vaccine plasmids in mixturesGene Therapy, 2004
- A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantumVeterinary Immunology and Immunopathology, 2003
- A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (S o Gon alo do Amaranto, RN)Vaccine, 2000
- Immunization of animals: from DNA to the dinner plateVeterinary Immunology and Immunopathology, 1999
- Genetic Immunization with Glycoprotein 63 cDNA Results in a Helper T Cell Type 1 Immune Response and Protection in a Murine Model of LeishmaniasisHuman Gene Therapy, 1998
- Humoral and cell-mediated immunity in natural and experimental canine leishmaniasisVeterinary Immunology and Immunopathology, 1995
- The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasisParasite Immunology, 1987